Literature DB >> 25613736

Dexmedetomidine on renal ischemia-reperfusion injury in rats: assessment by means of NGAL and histology.

Ana Lygia R de Carvalho1, Roberto B Vital, Cláudio M Kakuda, José R C Braz, Yara M M Castiglia, Leandro G Braz, Marília P Módolo, Odilon R G Ribeiro, Maria A Domingues, Norma S P Módolo.   

Abstract

BACKGROUND: Ischemic acute kidney injury is a common occurrence in the perioperative period and in critical patients admitted to intensive care units. The reestablishment of blood supply may worsen injury through the ischemia-reperfusion (I/R) mechanism. We investigated the effect of dexmedetomidine on the kidneys of rats subjected to an experimental I/R model.
METHODS: 34 rats anesthetized with isoflurane was undergone right nephrectomy and randomly assigned to four groups: Control C (saline solution); Dexmedetomidine D (dexmedetomidine); Sham S (saline solution); Sham with Dexmedetomidine SD (dexmedetomidine). The serum levels of neutrophil gelatinase-associated lipocalin (NGAL) were measured at time-points T1 (following stabilization), T2 (ischemia), T3 (reperfusion), T4 (12 h after of I/R). The kidneys were subjected to histological examination.
RESULTS: The NGAL levels were significantly higher at T4 compared with T1. Upon histological examination, the left kidneys in groups C and D exhibited a similar extent of cell injury.
CONCLUSION: The levels of NGAL did not indicate either protection against or worsening of kidney injury. Histological examination for acute tubular necrosis showed that dexmedetomidine did not protect the kidneys from I/R.

Entities:  

Keywords:  Histology; NGAL; ischemia; rat; reperfusion

Mesh:

Substances:

Year:  2015        PMID: 25613736     DOI: 10.3109/0886022X.2015.1006118

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

1.  Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?

Authors:  E Erkılıç; E Kesimci; F Alaybeyoğlu; I Kılınç; R Tural; A Yazgan; T Gümüş; A Sepici Dinçel; E G Dumlu; O Kanbak
Journal:  Drug Des Devel Ther       Date:  2017-03-08       Impact factor: 4.162

2.  TEMPOL has limited protective effects on renal oxygenation and hemodynamics but reduces kidney damage and inflammation in a rat model of renal ischemia/reperfusion by aortic clamping.

Authors:  Bulent Ergin; Rick Bezemer; Asli Kandil; Cihan Demirci-Tansel; Can Ince
Journal:  J Clin Transl Res       Date:  2015-09-30

3.  miR‑223‑3p/TIAL1 interaction is involved in the mechanisms associated with the neuroprotective effects of dexmedetomidine on hippocampal neuronal cells in vitro.

Authors:  Qi Wang; Hongmei Yu; Hong Yu; Meina Ma; Yali Ma; Rui Li
Journal:  Mol Med Rep       Date:  2018-12-11       Impact factor: 2.952

4.  Effects of dexmedetomidine on renal microcirculation in ischemia/reperfusion-induced acute kidney injury in rats.

Authors:  Wing-Sum Chan; Yu-Chang Yeh; Szu-Jen Yang; Chia-Ning Fan; Ming-Jiuh Wang; Shou-Zen Fan; Jui-Chang Tsai; Wei-Zen Sun
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

5.  Perioperative renal protection during cardiac surgery: A choice between dopamine and dexmedetomidine.

Authors:  Rajinder Singh Rawat; Said Musallam Al Maashani
Journal:  Ann Card Anaesth       Date:  2018 Jan-Mar

6.  Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury.

Authors:  Hengchang Li; Chengxiang Lu; Wenfei Yao; Lixin Xu; Jun Zhou; Bin Zheng
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.